1. Home
  2. IMKTA vs SPRY Comparison

IMKTA vs SPRY Comparison

Compare IMKTA & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMKTA
  • SPRY
  • Stock Information
  • Founded
  • IMKTA 1963
  • SPRY 2015
  • Country
  • IMKTA United States
  • SPRY United States
  • Employees
  • IMKTA N/A
  • SPRY N/A
  • Industry
  • IMKTA Food Chains
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMKTA Consumer Staples
  • SPRY Health Care
  • Exchange
  • IMKTA Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • IMKTA 1.2B
  • SPRY 1.4B
  • IPO Year
  • IMKTA N/A
  • SPRY N/A
  • Fundamental
  • Price
  • IMKTA $62.30
  • SPRY $15.69
  • Analyst Decision
  • IMKTA
  • SPRY Strong Buy
  • Analyst Count
  • IMKTA 0
  • SPRY 4
  • Target Price
  • IMKTA N/A
  • SPRY $28.75
  • AVG Volume (30 Days)
  • IMKTA 114.8K
  • SPRY 1.2M
  • Earning Date
  • IMKTA 08-07-2025
  • SPRY 08-05-2025
  • Dividend Yield
  • IMKTA 1.08%
  • SPRY N/A
  • EPS Growth
  • IMKTA N/A
  • SPRY N/A
  • EPS
  • IMKTA 3.26
  • SPRY N/A
  • Revenue
  • IMKTA $5,410,455,724.00
  • SPRY $97,122,000.00
  • Revenue This Year
  • IMKTA N/A
  • SPRY N/A
  • Revenue Next Year
  • IMKTA N/A
  • SPRY $140.40
  • P/E Ratio
  • IMKTA $18.75
  • SPRY N/A
  • Revenue Growth
  • IMKTA N/A
  • SPRY 971120.00
  • 52 Week Low
  • IMKTA $58.92
  • SPRY $7.55
  • 52 Week High
  • IMKTA $82.01
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • IMKTA 53.17
  • SPRY 60.81
  • Support Level
  • IMKTA $59.55
  • SPRY $14.77
  • Resistance Level
  • IMKTA $61.94
  • SPRY $16.23
  • Average True Range (ATR)
  • IMKTA 1.05
  • SPRY 0.73
  • MACD
  • IMKTA 0.11
  • SPRY 0.12
  • Stochastic Oscillator
  • IMKTA 83.97
  • SPRY 84.68

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: